T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α 1-Antitrypsin

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Baranovski, Boris M ^a   Freixo Lima, Gabriella S ^a   Lewis, Eli C ^a   Rider, Peleg ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; CYTOKINE; INTERLEUKIN 22; TRANSCRIPTION FACTOR;

ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; EPIGENETICS; GENE SILENCING; HELPER CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PHENOTYPIC PLASTICITY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; CELL DIFFERENTIATION; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ACUTE-PHASE PROTEINS; ADAPTIVE IMMUNITY; ALPHA 1-ANTITRYPSIN; CELL DIFFERENTIATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84947465935     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/184574     Document Type: Review

References (134)

1. T. Tada, T. Takemori, K. Okumura, M. Nonaka, and T. Tokuhisa, "Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Iaand Ia+ helper T cells, " Journal of Experimental Medicine, vol. 147, no. 2, pp. 446-458, 1978.
2. T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman, "Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, "TheJournal of Immunology, vol. 136, no. 7, pp. 2348-2357, 1986.
3. J. Magram, S. E. Connaughton, R. R. Warrier et al., "IL-12-deficient mice are defective in IFN production and type 1 cytokine responses, " Immunity, vol. 4, no. 5, pp. 471-481, 1996.
4. F. Mattner, J. Magram, J. Ferrante et al., "Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response, " European Journal of Immunology, vol. 26, no. 7, pp. 1553-1559, 1996.
5. T. Sornasse, P. V. Larenas, K. A. Davis, J. E. deVries, andH. Yssel, "Differentiation and stability of T helper 1 and 2 cells derived fromnaive human neonatalCD4+ Tcells, analyzedat the singlecell level, "The Journal of Experimental Medicine, vol. 184, no. 2, pp. 473-483, 1996.
6. M. Moser andK. M. Murphy, "Dendritic cell regulation ofTH1-TH2 development, " Nature Immunology, vol. 1, no. 3, pp. 199-205, 2000.
7. S. Agarwal, O. Avni, and A. Rao, "Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo, " Immunity, vol. 12, no. 6, pp. 643-652, 2000.
8. N. G. Jacobson, S. J. Szabo, R. M. Weber-Nordt et al., "Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4, " Journal of Experimental Medicine, vol. 181, no. 5, pp. 1755-1762, 1995.
9. S. J. Szabo, N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy, "Developmental commitment to the Th2 lineage by extinction of IL-12 signaling, " Immunity, vol. 2, no. 6, pp. 665-675, 1995.
10. M. Afkarian, J. R. Sedy, J. Yang et al., "T-bet is a STATI-induced regulator for IL-12R expression in näve CD4+ T cells, " Nature Immunology, vol. 3, no. 6, pp. 549-557, 2002.
11. I. M. Djuretic, D. Levanon, V. Negreanu, Y. Groner, A. Rao, and K. M. Ansel, "Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells, " Nature Immunology, vol. 8, no. 2, pp. 145-153, 2007.
12. F. W. Quelle, K. Shimoda, W. Thierfelder et al., "Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis, " Molecular and Cellular Biology, vol. 15, no. 6, pp. 3336-3343, 1995.
13. M. Kubo, J. Ransom, D. Webb, Y. Hashimoto, T. Tada, and T. Nakayama, "T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6, "The EMBO Journal, vol. 16, no. 13, pp. 4007-4020, 1997.
14. W. Ouyang, S. H. Ranganath, K. Weindel et al., "Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism, " Immunity, vol. 9, no. 5, pp. 745-755, 1998.
15. J. I. Kim, I.-C. Ho, M. J. Grusby, and L. H. Glimcher, "The transcription factor c-Maf controls the production of interleukin-4 but not otherTh2 cytokines, " Immunity, vol. 10, no. 6, pp. 745-751, 1999.
16. K. M. Murphy, W. Ouyang, J. D. Farrar et al., "Signaling and transcription in T helper development, " Annual Review of Immunology, vol. 18, pp. 451-494, 2000.
17. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, " Journal of ExperimentalMedicine, vol. 201, no. 2, pp. 233-240, 2005.
18. H. Park, Z. Li, X. O. Yang et al., "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, " Nature Immunology, vol. 6, no. 11, pp. 1133-1141, 2005.
19. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, " Nature Immunology, vol. 6, no. 11, pp. 1123-1132, 2005.
20. E. Rouvier, M.-F. Luciani, M.-G. Mattei, F. Denizot, and P. Golstein, "CTLA-8, cloned from an activated T cell, bearing AUrich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene, "TheJournal of Immunology, vol. 150, no. 12, pp. 5445-5456, 1993.
21. Z. Yao, S. L. Painter, W. C. Fanslow et al., "Human IL-17: a novel cytokine derived from T cells, " Journal of Immunology, vol. 155, no. 12, pp. 5483-5486, 1995.
22. R. Pappu, V. Ramirez-Carrozzi, N. Ota, W. Ouyang, and Y. Hu, "The IL-17 family cytokines in immunity and disease, " Journal of Clinical Immunology, vol. 30, no. 2, pp. 185-195, 2010.
23. E. Lockhart, A. M. Green, and J. L. Flynn, "IL-17 production is dominated by T cells rather than CD4 T cells during Mycobacterium tuberculosis infection, " Journal of Immunology, vol. 177, no. 7, pp. 4662-4669, 2006.
24. M. Chabaud, P. Garnero, J.-M. Dayer, P.-A. Guerne, F. Fossiez, and P. Miossec, "Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, " Cytokine, vol. 12, no. 7, pp. 1092-1099, 2000.
25. S. Fujino, A. Andoh, S. Bamba et al., "Increased expression of interleukin 17 in inflammatory bowel disease, " Gut, vol. 52, no. 1, pp. 65-70, 2003.
26. D. J. Cua, J. Sherlock, Y. Chen et al., "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, " Nature, vol. 421, no. 6924, pp. 744-748, 2003.
27. V. Gorbacheva, R. Fan, X. Li, and A. Valujskikh, "Interleukin-17 promotes early allograft inflammation, " American Journal of Pathology, vol. 177, no. 3, pp. 1265-1273, 2010.
28. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, "TGF in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, " Immunity, vol. 24, no. 2, pp. 179-189, 2006.
29. T. Korn, E. Bettelli, W. Gao et al., "IL-21 initiates an alternative pathway to induce proinflammatory T 17 cells, " Nature, vol. 448, no. 7152, pp. 484-487, 2007.
30. X. O. Yang, B. P. Pappu, R. Nurieva et al., "T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR and ROR, " Immunity, vol. 28, no. 1, pp. 29-39, 2008.
31. A. N. Mathur, H.-C. Chang, D. G. Zisoulis et al., "Stat3 and Stat4 direct development of IL-17-secreting Th cells, " The Journal of Immunology, vol. 178, no. 8, pp. 4901-4907, 2007.
32. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, " Journal of Immunology, vol. 155, no. 3, pp. 1151-1164, 1995.
33. W. J. Penhale, A. Farmer, R. P. McKenna, and W. J. Irvine, "Spontaneous thyroiditis in thymectomized and irradiatedWistar rats, " Clinical and Experimental Immunology, vol. 15, no. 2, pp. 225-236, 1973.
34. A. Kojima and R. T. Prehn, "Genetic susceptibility to postthymectomy autoimmune diseases in mice, " Immunogenetics, vol. 14, no. 1-2, pp. 15-27, 1981.
35. W. J. Penhale, W. J. Irvine, J. R. Inglis, and A. Farmer, "Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitutionwith normal lymphoid cells, " Clinical and Experimental Immunology, vol. 25, no. 1, pp. 6-16, 1976.
36. S. Sakaguchi, T. Takahashi, and Y. Nishizuka, "Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirements of Lyt-1 cells in normal female mice for the prevention of oophoritis, " Journal of ExperimentalMedicine, vol. 156, no. 6, pp. 1577-1586, 1982.
37. R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi, "Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, " Journal of Experimental Medicine, vol. 201, no. 5, pp. 723-735, 2005.
38. M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild et al., "Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, " Nature Genetics, vol. 27, no. 1, pp. 68-73, 2001.
39. S. Hori, T. Nomura, and S. Sakaguchi, "Control of regulatory T cell development by the transcription factor Foxp3, " Science, vol. 299, no. 5609, pp. 1057-1061, 2003.
40. S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, "FOXP3+ regulatory T cells in the human immune system, " Nature Reviews Immunology, vol. 10, no. 7, pp. 490-500, 2010.
41. Y. Carrier, J. Yuan, V. K. Kuchroo, andH. L. Weiner, "Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells byTh3 cells derived fromTGF-T cell-transgenic mice, " The Journal of Immunology, vol. 178, no. 1, pp. 179-185, 2007.
42. P. L. Vieira, J. R. Christensen, S. Minaee et al., "IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells, " Journal of Immunology, vol. 172, no. 10, pp. 5986-5993, 2004.
43. A. Awasthi, Y. Carrier, J. P. S. Peron et al., "A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells, " Nature Immunology, vol. 8, no. 12, pp. 1380-1389, 2007.
44. R. Bacchetta, M. Bigler, J.-L. Touraine et al., "High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells, " The Journal of Experimental Medicine, vol. 179, no. 2, pp. 493-502, 1994.
45. M. G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings, "Interleukin-10-secreting type 1 regulatory T cells in rodents and humans, " Immunological Reviews, vol. 212, no. 1, pp. 28-50, 2006.
46. N. Gagliani, T. Jofra, A. Stabilini et al., "Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant, " Diabetes, vol. 59, no. 2, pp. 433-439, 2010.
47. M. Battaglia, S. Gregori, R. Bacchetta, and M.-G. Roncarolo, "Tr1 cells: fromdiscovery to their clinical application, " Seminars in Immunology, vol. 18, no. 2, pp. 120-127, 2006.
48. M. H. Kaplan, U. Schindler, S. T. Smiley, and M. J. Grusby, "Stat6 is required for mediating responses to IL-4 and for the development ofTh2 cells, " Immunity, vol. 4, no. 3, pp. 313-319, 1996.
49. R. I. Nurieva, Y. Chung, D. Hwang et al., "Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages, " Immunity, vol. 29, no. 1, pp. 138-149, 2008.
50. D. Breitfeld, L. Ohl, E. Kremmer et al., "Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production, " Journal of Experimental Medicine, vol. 192, no. 11, pp. 1545-1551, 2000.
51. P. Schaerli, K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser, "CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function, " Journal of Experimental Medicine, vol. 192, no. 11, pp. 1553-1562, 2000.
52. Y. S. Choi, R. Kageyama, D. Eto et al., "ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6, " Immunity, vol. 34, no. 6, pp. 932-946, 2011.
53. M. Pepper, A. J. Pagán, B. Z. Igyártó, J. J. Taylor, and M. K. Jenkins, "Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells, " Immunity, vol. 35, no. 4, pp. 583-595, 2011.
54. R. J. Johnston, A. C. Poholek, D. DiToro et al., "Bcl6 andBlimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation, " Science, vol. 325, no. 5943, pp. 1006-1010, 2009.
55. R. I. Nurieva, Y. Chung, G. J. Martinez et al., "Bcl6mediates the development of T follicular helper cells, " Science, vol. 325, no. 5943, pp. 1001-1005, 2009.
56. Y. S. Choi, D. Eto, J. A. Yang, C. Lao, andS. Crotty, "Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation, " Journal of Immunology, vol. 190, no. 7, pp. 3049-3053, 2013.
57. J. M. Odegard, B. R. Marks, L. D. Diplacido et al., "ICOSdependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity, " Journal of Experimental Medicine, vol. 205, no. 12, pp. 2873-2886, 2008.
58. J. A. Bubier, T. J. Sproule, O. Foreman et al., "A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1518-1523, 2009.
59. C. C. Goodnow, C. G. Vinuesa, K. L. Randall, F. MacKay, and R. Brink, "Control systems and decision making for antibody production, " Nature Immunology, vol. 11, no. 8, pp. 681-688, 2010.
60. N. Fazilleau, L. Mark, L. J. McHeyzer-Williams, and M. G. McHeyzer-Williams, "Follicular helper T cells: lineage and location, " Immunity, vol. 30, no. 3, pp. 324-335, 2009.
61. M. A. Linterman and C. G. Vinuesa, "Signals that influence T follicular helper cell differentiation and function, " Seminars in Immunopathology, vol. 32, no. 2, pp. 183-196, 2010.
62. M. A. Linterman, R. J. Rigby, R. K. Wong et al., "Follicular helper T cells are required for systemic autoimmunity, " Journal of Experimental Medicine, vol. 206, no. 3, pp. 561-576, 2009.
63. M.-H. Xie, S. Aggarwal, W.-H. Ho et al., "Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, " Journal of Biological Chemistry, vol. 275, no. 40, pp. 31335-31339, 2000.
64. S. C. Liang, X. Y. Tan, D. P. Luxenberg et al., "Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, " The Journal of Experimental Medicine, vol. 203, pp. 2271-2279, 2006.
65. K. Wolk and R. Sabat, "Interleukin-22: a novel T-and NKcell derived cytokine that regulates the biology of tissue cells, " Cytokine and Growth Factor Reviews, vol. 17, no. 5, pp. 367-380, 2006.
66. N. Satoh-Takayama, C. A. J. Vosshenrich, S. Lesjean-Pottier et al., "Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense, " Immunity, vol. 29, no. 6, pp. 958-970, 2008.
67. H. Hamada, M. D. L. L. Garcia-Hernandez, J. B. Reome et al., "Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge, " Journal of Immunology, vol. 182, no. 6, pp. 3469-3481, 2009.
68. B. Martin, K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen, "Interleukin-17-producing T cells selectively expand in response to pathogen products and environmental signals, " Immunity, vol. 31, no. 2, pp. 321-330, 2009.
69. H. Fujita, K. E. Nograles, T. Kikuchi, J. Gonzalez, J. A. Carucci, and J. G. Krueger, "Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21795-21800, 2009.
70. K. Wolk, E. Witte, K. Witte, K. Warszawska, and R. Sabat, "Biology of interleukin-22, " Seminars in Immunopathology, vol. 32, no. 1, pp. 17-31, 2010.
71. A.-G. Besnard, R. Sabat, L. Dumoutier et al., "Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A, " American Journal of Respiratory and Critical CareMedicine, vol. 183, no. 9, pp. 1153-1163, 2011.
72. P. J. Chestovich, Y. Uchida, W. Chang et al., "Interleukin-22: implications for liver ischemia-reperfusion injury, " Transplantation, vol. 93, no. 5, pp. 485-492, 2012.
73. H. M. McGee, B. A. Schmidt, C. J. Booth et al., "IL-22 promotes fibroblast-mediatedwound repair in the skin, " Journal of Investigative Dermatology, vol. 133, no. 5, pp. 1321-1329, 2013.
74. L. F. da Rocha Jr., A. L. B. P. Duarte, A. T. Dantas et al., "Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity, "The Journal of Rheumatology, vol. 39, no. 7, pp. 1320-1325, 2012.
75. A. Mathian, C. Parizot, K. Dorgham et al., "Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions, " Annals of the Rheumatic Diseases, vol. 71, no. 7, pp. 1227-1234, 2012.
76. S. Trifari, C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits, "Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T-17, T 1 and T 2 cells, " Nature Immunology, vol. 10, no. 8, pp. 864-871, 2009.
77. T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto, "Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, " Nature Immunology, vol. 10, no. 8, pp. 857-863, 2009.
78. S. Eyerich, K. Eyerich, D. Pennino et al., "Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling, " The Journal of Clinical Investigation, vol. 119, no. 12, pp. 3573-3585, 2009.
79. H. Li and A. Rostami, "IL-9: Basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity, " Journal of Neuroimmune Pharmacology, vol. 5, no. 2, pp. 198-209, 2010.
80. E. C. Nowak and R. J. Noelle, "Interleukin-9 as a T helper type 17 cytokine, " Immunology, vol. 131, no. 2, pp. 169-173, 2010.
81. V. Staudt, E. Bothur, M. Klein et al., "Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells, " Immunity, vol. 33, no. 2, pp. 192-202, 2010.
82. M. Veldhoen, C. Uyttenhove, J. van Snick et al., "Transforming growth factor-'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset, " Nature Immunology, vol. 9, no. 12, pp. 1341-1346, 2008.
83. E. Schmitt, T. Germann, S. Goedert et al., "IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-and IL-4, and is inhibited by IFN-, " The Journal of Immunology, vol. 153, no. 9, pp. 3989-3996, 1994.
84. M. T. Wong, J. J. Ye, M. N. Alonso et al., "Regulation of human Th9differentiation by type I interferons and IL-21, " Immunology and Cell Biology, vol. 88, no. 6, pp. 624-631, 2010.
85. P. Monteyne, J.-C. Renauld, J. Van Broeck, D. W. Dunne, F. Brombacher, and J.-P. Coutelier, "IL-4-independent regulation of in vivo IL-9 expression, " Journal of Immunology, vol. 159, no. 6, pp. 2616-2623, 1997.
86. R. Goswami, R. Jabeen, R. Yagi et al., "STAT6-dependent regulation of Th9 development, " Journal of Immunology, vol. 188, no. 3, pp. 968-975, 2012.
87. P. Angkasekwinai, S. H. Chang, M. Thapa, H. Watarai, and C. Dong, "Regulation of IL-9 expression by IL-25 signaling, " Nature Immunology, vol. 11, no. 3, pp. 250-256, 2010.
88. A. Ramming, D. Druzd, J. Leipe, H. Schulze-Koops, and A. Skapenko, "Maturation-related histone modifications in the PU. 1 promoter regulate Th9-cell development, " Blood, vol. 119, no. 20, pp. 4665-4674, 2012.
89. L. Blom, B. C. Poulsen, B. M. Jensen, A. Hansen, and L. K. Poulsen, "IL-33 induces IL-9 production in humanCD4+Tcells and basophils, " PLoS ONE, vol. 6, no. 7, Article ID e21695, 2011.
90. A. Jäger, V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo, "Th1, Th17, andTh9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes, " Journal of Immunology, vol. 183, no. 11, pp. 7169-7177, 2009.
91. H.-C. Chang, S. Sehra, R. Goswami et al., "The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation, " Nature Immunology, vol. 11, no. 6, pp. 527-534, 2010.
92. E. Bettelli, Y. Carrier, W. Gao et al., "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, " Nature, vol. 441, no. 7090, pp. 235-238, 2006.
93. D. Mucida, Y. Park, G. Kim et al., "Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid, " Science, vol. 317, no. 5835, pp. 256-260, 2007.
94. L. Xu, A. Kitani, I. Fuss, and W. Strober, "Cutting edge: regulatory T cells induce CD4+CD25?Foxp3? T cells or are selfinduced to becomeTh17 cells in the absence of exogenous TGF-, " Journal of Immunology, vol. 178, no. 11, pp. 6725-6729, 2007.
95. X. O. Yang, R. Nurieva, G. J. Martinez et al., "Molecular antagonism and plasticity of regulatory and inflammatory T cell programs, " Immunity, vol. 29, no. 1, pp. 44-56, 2008.
96. X. Zhou, S. L. Bailey-Bucktrout, L. T. Jeker et al., "Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, " Nature Immunology, vol. 10, no. 9, pp. 1000-1007, 2009.
97. D. Bending, H. de la Peña, M. Veldhoen et al., "Highly purified Th17 cells from BDC2. 5NOD mice convert into Th1-like cells in NOD/SCID recipient mice, " Journal of Clinical Investigation, vol. 119, no. 3, pp. 565-572, 2009.
98. G. Oldenhove, N. Bouladoux, E. A. Wohlfert et al., "Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection, " Immunity, vol. 31, no. 5, pp. 772-786, 2009.
99. A. T. Bauquet, H. Jin, A. M. Paterson et al., "The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells, " Nature Immunology, vol. 10, no. 2, pp. 167-175, 2009.
100. M. Tsuji, N. Komatsu, S. Kawamoto et al., "Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches, " Science, vol. 323, no. 5920, pp. 1488-1492, 2009.
101. Y. K. Lee, H. Turner, C. L. Maynard et al., "Late developmental plasticity in the T helper 17 lineage, " Immunity, vol. 30, no. 1, pp. 92-107, 2009.
102. A. N. Hegazy, M. Peine, C. Helmstetter et al., "Interferons directTh2 cell reprogramming to generate a stable GATA-3+Tbet + cell subset with combined Th2 and Th1 cell functions, " Immunity, vol. 32, no. 1, pp. 116-128, 2010.
103. J. R. Schoenborn, M. O. Dorschner, M. Sekimata et al., "Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma, " Nature Immunology, vol. 8, pp. 732-742, 2007.
104. G. Wei, L. Wei, J. Zhu et al., "Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells, " Immunity, vol. 30, no. 1, pp. 155-167, 2009.
105. R. Mukasa, A. Balasubramani, Y. K. Lee et al., "Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage, " Immunity, vol. 32, no. 5, pp. 616-627, 2010.
106. B. E. Bernstein, T. S. Mikkelsen, X. Xie et al., "A bivalent chromatin structure marks key developmental genes in embryonic stem cells, " Cell, vol. 125, no. 2, pp. 315-326, 2006.
107. O. Guttman, B. M. Baranovski, R. Schuster et al., "Acute-phase protein 1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats, " Clinical & Experimental Immunology, vol. 179, no. 2, pp. 161-172, 2015.
108. R. W. Carrell, " 1-antitrypsin: molecular pathology, leukocytes, and tissue damage, "The Journal of Clinical Investigation, vol. 78, no. 6, pp. 1427-1431, 1986.
109. L. J. Scott, G. I. Russell, N. B. Nixon, P. T. Dawes, and D. L. Mattey, "Oxidation of 1-proteinase inhibitor by the myeloperoxidase-hydrogen peroxidase system promotes binding to immunoglobulin A, " Biochemical and Biophysical Research Communications, vol. 255, no. 3, pp. 562-567, 1999.
110. Z. Li, S. Alam, J. Wang, C. S. Sandstrom, S. Janciauskiene, and R. Mahadeva, "Oxidized 1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema, " The American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 297, no. 2, pp. L388-L400, 2009.
111. F. Moraga and S. Janciauskiene, "Activation of primary human monocytes by the oxidized form of 1-antitrypsin, " The Journal of Biological Chemistry, vol. 275, no. 11, pp. 7693-7700, 2000.
112. J. Choi, C. A. Malakowsky, J. M. Talent, C. C. Conrad, and R. W. Gracy, "Identification of oxidized plasma proteins in Alzheimer's disease, " Biochemical and Biophysical Research Communications, vol. 293, no. 5, pp. 1566-1570, 2002.
113. C. Banfi, M. Brioschi, S. Barcella et al., "Oxidized proteins in plasma of patients with heart failure: role in endothelial damage, " European Journal of Heart Failure, vol. 10, no. 3, pp. 244-251, 2008.
114. N. Izumi-Yoneda, A. Toda, M. Okabe et al., "Alpha 1 antitrypsin activity is decreased in human amnion in premature rupture of the fetal membranes, " Molecular Human Reproduction, vol. 15, no. 1, pp. 49-57, 2009.
115. A. Churg, R. D. Wang, C. Xie, and J. L. Wright, "-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse, " American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 2, pp. 199-207, 2003.
116. H. M. Morrison, D. Burnett, and R. A. Stockley, "The effect of catalase and methionine-S-oxide reductase on oxidised alpha 1-proteinase inhibitor, " Biological Chemistry Hoppe-Seyler, vol. 367, no. 5, pp. 371-378, 1986.
117. J. S. Parmar, R. Mahadeva, B. J. Reed et al., "Polymers of 1-antitrypsin are chemotactic for human neutrophils: a newparadigm for the pathogenesis of emphysema, " American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 6, pp. 723-730, 2002.
118. D. E. Ochayon, M. Mizrahi, G. Shahaf, B. M. Baranovski, and E. C. Lewis, "Human 1-antitrypsin binds to heat-shock protein gp96 and protects from endogenous gp96-mediated injury in vivo, " Frontiers in Immunology, vol. 4, article 320, 2013.
119. G. B. Pott, K. S. Beard, C. L. Bryan, D. T. Merrick, andL. Shapiro, "Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells, " Frontiers in Public Health, vol. 1, article 19, 2013.
120. S. Subramanian, G. Shahaf, E. Ozeri et al., "Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice, " Metabolic Brain Disease, vol. 26, no. 2, pp. 107-113, 2011.
121. H. Tilg, E. Vannier, G. Vachino, C. A. Dinarello, and J. W. Mier, "Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 synthesis by human peripheral blood mononuclear cells, "The Journal of Experimental Medicine, vol. 178, no. 5, pp. 1629-1636, 1993.
122. E. Ozeri, M. Mizrahi, G. Shahaf, and E. C. Lewis, "-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells, " The Journal of Immunology, vol. 189, no. 1, pp. 146-153, 2012.
123. C. Grimstein, Y.-K. Choi, C. H. Wasserfall et al., "Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model, " Journal of Translational Medicine, vol. 9, article 21, 2011.
124. A. M. Marcondes, X. Li, L. Tabellini et al., "Inhibition of IL-32 activation by-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model, " Blood, vol. 118, no. 18, pp. 5031-5039, 2011.
125. C. B. Collins, C. M. Aherne, S. F. Ehrentraut et al., "Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis, " Inflammatory Bowel Diseases, vol. 19, no. 9, pp. 1964-1973, 2013.
126. M. Koulmanda, M. Bhasin, L. Hoffman et al., "Curative and cell regenerative effects of 1-antitrypsin treatment in autoimmune diabeticNODmice, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16242-16247, 2008.
127. S. Song, K. Goudy, M. Campbell-Thompson et al., "Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice, " Gene Therapy, vol. 11, no. 2, pp. 181-186, 2004.
128. E. C. Lewis, L. Shapiro, O. J. Bowers, and C. A. Dinarello, " 1-antitrypsinmonotherapy prolongs islet allograft survival in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 34, pp. 12153-12158, 2005.
129. E. C. Lewis, M. Mizrahi, M. Toledano et al., " 1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16236-16241, 2008.
130. B. J. O'Sullivan, H. E. Thomas, S. Pai et al., "IL-1 breaks tolerance through expansion of CD25+ effector T cells, " The Journal of Immunology, vol. 176, no. 12, pp. 7278-7287, 2006.
131. A. Abecassis, R. Schuster, G. Shahaf et al., " 1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation, " Cellular & Molecular Immunology, vol. 11, no. 4, pp. 377-386, 2014.
132. M. Mizrahi, P. Cal, M. Rosenthal et al., "Human 1-antitrypsin modifies B-lymphocyte responses during allograft transplantation, " Immunology, vol. 140, no. 3, pp. 362-373, 2013.
133. E. Ashkenazi, B. M. Baranovski, G. Shahaf, and E. C. Lewis, "Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy, " PLoS ONE, vol. 8, no. 5, Article ID e63625, 2013.
134. Y. Wang, H.-J. Yan, S.-Y. Zhou et al., "The immunoregulation effect of alpha 1-antitrypsin prolong-cell survival after transplantation, " PLoS ONE, vol. 9, no. 4, Article ID e94548, 2014.